Hims & Hers Health, Inc. (HIMS) spreader of May calls into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Hims & Hers earnings preview: BofA says company lost GLP-1 share in 1Q
May 11, 2026 12:00 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reports first-quarter results after the close on Monday, with Wall Street focused on the extent of market share losses, early signs of stabilization in April, and whether the company's nascent peptide opportunity can offset near-term headwinds in its core business.
Analyst consensus stands at $616.85 million in revenue and EPS... More
